Selectins create transient contacts between circulating leukocytes and the vascular endothelium, producing the rolling phase rather than immediate arrest. This slows cells sufficiently for tissue-derived signals to influence their next behavior. Without this initial, reversible interaction, leukocytes would have less opportunity to receive the chemokine signals that prepare them for stronger attachment and movement into affected tissue.
Chemokines presented during rolling activate leukocyte integrins, changing the cells’ adhesive behavior. Activated integrins then support firm attachment to the endothelium, replacing the weak, transient contacts produced by selectins. This transition is essential because it positions leukocytes for the next step, diapedesis, rather than allowing them to continue circulating past the tissue signal.
Signals originating in tissues help determine which circulating leukocytes are recruited and when recruitment occurs. Infection, injury, and cancer can each create local conditions that direct cells toward affected sites. The resulting trafficking pattern supports immune surveillance and defense, but persistent or poorly regulated signals may instead promote chronic inflammation, autoimmunity, or tissue damage.
The sequence proceeds through increasingly stable interactions: selectins initiate rolling, chemokines activate leukocyte integrins, integrins establish firm adhesion, and the attached cell then crosses the vessel wall by diapedesis. Each stage prepares the next, creating a controlled progression from bloodstream circulation to tissue localization. This order helps coordinate immune-cell access rather than producing indiscriminate infiltration.
Therapeutic strategies can either enhance protective immune recruitment or limit harmful leukocyte infiltration. Increasing recruitment may support defense where immune access is beneficial, whereas reducing recruitment may help control chronic inflammation, autoimmune responses, or tissue damage. Because trafficking includes sequential signaling and adhesion events, treatment approaches can be considered in relation to the stage that needs adjustment.
Cancer is one of the tissue contexts in which local signals can direct immune-cell recruitment. Studying these movements helps explain how leukocytes reach tumor-associated sites and supports efforts to modify immune access. The same framework also connects cancer research with infection, injury, and inflammatory disease, where researchers must distinguish protective recruitment from infiltration that contributes to pathology.